Estimation of the stage-wise costs of breast cancer in Germany using a modeling approach
Breast cancer (BC) is a heterogeneous disease representing a substantial economic burden. In order to develop policies that successfully decrease this burden, the factors affecting costs need to be fully understood. Evidence suggests that early-stage BC has a lower cost than a late stage BC. We aim...
Main Authors: | Shah Alam Khan, Karla Hernandez-Villafuerte, Diego Hernandez, Michael Schlander |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2022.946544/full |
Similar Items
-
HTA Agencies Need Evidence-Informed Deliberative Processes; Comment on “Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”
by: Michael Schlander
Published: (2021-03-01) -
Standardization of Stage-Wise Requirement of Nutrients in Banana Cv. Grande Naine (AAA)
by: T N Balamohan, et al.
Published: (2015-12-01) -
Would initiating colorectal cancer screening from age of 45 be cost-effective in Germany? An individual-level simulation analysis
by: Min Wai Lwin, et al.
Published: (2024-02-01) -
Health technology assessment (HTA) and economic evaluation: efficiency or fairness first
by: Jeff Richardson, et al.
Published: (2019-01-01) -
Increased healthcare costs by later stage cancer diagnosis
by: November McGarvey, et al.
Published: (2022-09-01)